Page last updated: 2024-12-10

peptidoglycan pentapeptide-mdap3

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

peptidoglycan pentapeptide-mDap3: peptide portion of peptidoglycan-mDap3 in Gram-negative bacteria [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3035036
MeSH IDM0102528

Synonyms (8)

Synonym
peptidoglycan pentapeptide-mdap3
d-alanine, n-(n-(n2-(n2-(n-(n-acetyl-4-o-(2-(acetylamino)-2-deoxy-beta-d-glucopyranosyl)muramoyl)-l-alanyl)-d-alpha-glutaminyl)-(r*,s*)-6-carboxylysyl)-d-alanyl)-
d-alanine, n-(n-acetyl-4-o-(2-(acetylamino)-2-deoxy-beta-d-glucopyranosyl)muramoyl)-l-alanyl-d-alpha-glutaminyl-meso-alpha,epsilon-diaminopimelyl-d-alanyl-
n-acetylglucosaminyl-n-acmu-ala-iso-gln-meso-diaminopimelic acid-ala-ala
n-acetylglucosaminyl-n-acetylmuramyl-l-alanyl-d-isoglutaminyl-meso-diaminopimelic acid-d-alanyl-d-alanine
peptidoglycan monomer-mdap3
73715-37-4
(2s,6s)-6-[[(2r)-2-[[(2s)-2-[[(2r)-2-[(2s,3r,4r,5s,6r)-3-acetamido-5-[(2s,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoyl]amino]-2-amino-

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The antineoplastic effects of PGM depend strictly on the dosage and treatment schedule used."( Antitumor and antimetastatic activity of the immunoadjuvant peptidoglycan monomer PGM in mice bearing MCa mammary carcinoma.
Hrsak, I; Sava, G; Tomasic, J, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (36.00)18.7374
1990's7 (28.00)18.2507
2000's9 (36.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.02 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]